These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 18691257

  • 1. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB, Schmiegelow K, Schroeder H.
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [Abstract] [Full Text] [Related]

  • 2. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
    Seidemann K, Book M, Zimmermann M, Meyer U, Welte K, Stanulla M, Reiter A.
    Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
    Zheng MM, Yue LJ, Chen XW, Wen FQ, Li CG, Yang CL, Xie C, Ding H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.
    Bernbeck B, Mauz-Körholz C, Zotz RB, Göbel U.
    Klin Padiatr; 2003 Mar; 215(6):327-31. PubMed ID: 14677097
    [Abstract] [Full Text] [Related]

  • 6. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R, Rentsch K, Di Paolo E, Popovic MB.
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [Abstract] [Full Text] [Related]

  • 9. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS, Ahmed TM.
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [Abstract] [Full Text] [Related]

  • 10. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.
    Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV.
    J Clin Oncol; 2003 Aug 15; 21(16):3084-91. PubMed ID: 12915598
    [Abstract] [Full Text] [Related]

  • 11. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
    Shimasaki N, Mori T, Torii C, Sato R, Shimada H, Tanigawara Y, Kosaki K, Takahashi T.
    J Pediatr Hematol Oncol; 2008 May 15; 30(5):347-52. PubMed ID: 18458567
    [Abstract] [Full Text] [Related]

  • 12. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
    Adam de Beaumais T, Dervieux T, Fakhoury M, Medard Y, Azougagh S, Zhang D, Yakouben K, Jacqz-Aigrain E.
    Cancer Chemother Pharmacol; 2010 Sep 15; 66(4):653-8. PubMed ID: 20033410
    [Abstract] [Full Text] [Related]

  • 13. [Association between mthfr gene polymorphisms and toxicity of HDMTX chemotherapy in acute lymphocytic leukemia].
    Liu JX, Chen JP, Tan W, Lin DX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun 15; 16(3):488-92. PubMed ID: 18549614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
    Frandsen TL, Abrahamsson J, Lausen B, Vettenranta K, Heyman M, Behrentz M, Castor A, Wehner PS, Frost BM, Andersen EW, Schmiegelow K.
    Br J Haematol; 2011 Oct 15; 155(2):244-7. PubMed ID: 21848519
    [Abstract] [Full Text] [Related]

  • 19. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A, Mura R, Fraschini D, Gornati G, Scovena E, Gervasoni A, Uderzo C, Masera G.
    Haematologica; 1992 Oct 15; 77(1):49-53. PubMed ID: 1398282
    [Abstract] [Full Text] [Related]

  • 20. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z.
    Leuk Lymphoma; 2009 Jun 15; 50(6):912-7. PubMed ID: 19391036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.